GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice T Kempf, A Zarbock, C Widera, S Butz, A Stadtmann, J Rossaint, ... Nature medicine 17 (5), 581-588, 2011 | 568 | 2011 |
New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management F Kroschinsky, F Stölzel, S von Bonin, G Beutel, M Kochanek, M Kiehl, ... Critical Care 21, 1-11, 2017 | 471 | 2017 |
Vascular complications in patients undergoing femoral cannulation for extracorporeal membrane oxygenation support T Bisdas, G Beutel, G Warnecke, MM Hoeper, C Kuehn, A Haverich, ... The Annals of thoracic surgery 92 (2), 626-631, 2011 | 365 | 2011 |
High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics M Heuser, G Beutel, J Krauter, K Döhner, N von Neuhoff, ... Blood 108 (12), 3898-3905, 2006 | 283 | 2006 |
Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic … JT Kielstein, G Beutel, S Fleig, J Steinhoff, TN Meyer, C Hafer, ... Nephrology Dialysis Transplantation 27 (10), 3807-3815, 2012 | 263 | 2012 |
Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score F Pappalardo, M Pieri, T Greco, N Patroniti, A Pesenti, A Arcadipane, ... Intensive care medicine 39, 275-281, 2013 | 256 | 2013 |
Associations between ventilator settings during extracorporeal membrane oxygenation for refractory hypoxemia and outcome in patients with acute respiratory distress syndrome: a … A Serpa Neto, M Schmidt, LCP Azevedo, T Bein, L Brochard, G Beutel, ... Intensive care medicine 42, 1672-1684, 2016 | 208 | 2016 |
Renal function and survival in 200 patients undergoing ECMO therapy JT Kielstein, AM Heiden, G Beutel, J Gottlieb, O Wiesner, C Hafer, ... Nephrology Dialysis Transplantation 28 (1), 86-90, 2013 | 194 | 2013 |
COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry MM Rüthrich, C Giessen-Jung, S Borgmann, AY Classen, S Dolff, ... Annals of hematology 100, 383-393, 2021 | 185 | 2021 |
Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German … M Kochanek, E Schalk, M von Bergwelt-Baildon, G Beutel, D Buchheidt, ... Annals of hematology 98, 1051-1069, 2019 | 179 | 2019 |
Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1‐phosphate C Bode, SC Sensken, U Peest, G Beutel, F Thol, B Levkau, Z Li, R Bittman, ... Journal of cellular biochemistry 109 (6), 1232-1243, 2010 | 178 | 2010 |
A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 … JL Harousseau, G Martinelli, WW Jedrzejczak, JM Brandwein, ... Blood, The Journal of the American Society of Hematology 114 (6), 1166-1173, 2009 | 160 | 2009 |
Neurological immune related adverse events associated with nivolumab, ipilimumab, and pembrolizumab therapy—review of the literature and future outlook N Möhn, G Beutel, R Gutzmer, P Ivanyi, I Satzger, T Skripuletz Journal of Clinical Medicine 8 (11), 1777, 2019 | 138 | 2019 |
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on … S Cesaro, P Ljungman, M Mikulska, HH Hirsch, M von Lilienfeld-Toal, ... Leukemia 36 (6), 1467-1480, 2022 | 126 | 2022 |
Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection G Beutel, O Wiesner, M Eder, C Hafer, AS Schneider, JT Kielstein, C Kühn, ... Critical Care 15, 1-8, 2011 | 123 | 2011 |
Artificial hallucination: GPT on LSD? G Beutel, E Geerits, JT Kielstein Critical Care 27 (1), 148, 2023 | 106 | 2023 |
Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced … P Schöffski, B Thate, G Beutel, O Bolte, D Otto, M Hofmann, A Ganser, ... Annals of Oncology 15 (4), 671-679, 2004 | 98 | 2004 |
Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study C Hafer, P Golla, M Gericke, G Eden, G Beutel, JJ Schmidt, BMW Schmidt, ... International urology and nephrology 48, 133-138, 2016 | 96 | 2016 |
Consensus statement for cancer patients requiring intensive care support MG Kiehl, G Beutel, B Böll, D Buchheidt, R Forkert, V Fuhrmann, P Knöbl, ... Annals of hematology 97, 1271-1282, 2018 | 90 | 2018 |
Intensive Care in Hematological and Oncological Patients (iCHOP) Collaborative Group. New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of … F Kroschinsky, F Stölzel, S von Bonin, G Beutel, M Kochanek, M Kiehl, ... Crit Care 21 (1), 89, 2017 | 89 | 2017 |